Mariner, LLC Amicus Therapeutics, Inc. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 21,129 shares of FOLD stock, worth $208,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,129

Previous 30,206 30.05%

Holding current value

$208,965

Previous $299,000 24.75%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$9.55 - $12.09 $86,685 - $109,740	-9,077 Reduced 30.05%	21,129 $225,000
Q2 2024 Aug 13, 2024	SELL	$9.04 - $11.75 $17,609 - $22,889	-1,948 Reduced 6.06%	30,206 $299,000
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $2,754 - $3,431	241 Added 0.76%	32,154 $378,000
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $8,992 - $13,097	-902 Reduced 2.75%	31,913 $452,000
Q3 2023 Nov 13, 2023	SELL	$11.78 - $13.86 $22,005 - $25,890	-1,868 Reduced 5.39%	32,815 $399,000
Q2 2023 Aug 11, 2023	SELL	$10.72 - $13.3 $4,620 - $5,732	-431 Reduced 1.23%	34,683 $435,000
Q1 2023 May 12, 2023	BUY	$10.91 - $13.54 $10,277 - $12,754	942 Added 2.76%	35,114 $389,000
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $86,448 - $111,010	8,741 Added 34.37%	34,172 $417,000
Q3 2022 Nov 10, 2022	BUY	$9.82 - $12.75 $1,846 - $2,397	188 Added 0.74%	25,431 $265,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $6,821 - $12,176	-1,095 Reduced 4.16%	25,243 $271,000
Q1 2022 May 13, 2022	BUY	$7.89 - $12.48 $27,922 - $44,166	3,539 Added 15.52%	26,338 $249,000
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $223,886 - $283,619	22,799 New	22,799 $263,000
Q2 2021 Aug 24, 2021	SELL	$8.71 - $10.72 $179,486 - $220,907	-20,607 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$9.2 - $23.86 $189,584 - $491,683	20,607 New	20,607 $203,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.77B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account